Arena Pharmaceuticals Financial Statements
Arena Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Arena Pharmaceuticals Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 9.8 | 19.3 | 30.6 |
| Gross Profit ($ mil.) | 1.3 | -- | -- |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (237.6) | (145.3) | (88.3) |
| Diluted EPS (Net Income) | (3.24) | (2.31) | (1.89) |
Arena Pharmaceuticals Quarterly Statements
| Quarter Ending Jun 09 | Quarter Ending Mar 09 | Quarter Ending Dec 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 2.4 | 2.7 | 2.7 |
| Gross Profit ($ mil.) | 0.8 | 1.3 | 0.5 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (38.0) | (50.6) | (62.2) |
| Diluted EPS (Net Income) | (0.48) | (0.68) | (0.84) |
Arena Pharmaceuticals Stock Quote & Chart
11/09/09 16:00:01 EST •
NASDAQ •
3.59
•
 +0.1000
•
+2.8653 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Arena Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 27.25 | 16.45 | 7.01 |
| Price/Earnings Ratio | (1.27) | 384.62 | 25.51 |
| Price/Book Ratio | 7.19 | 3.53 | 6.74 |
| Price/Cash Flow Ratio | (1.35) | 80.00 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Arena Pharmaceuticals Financial Ratios
Arena Pharmaceuticals Competitive Intelligence
| Abbott Labs | Hoffmann-La Roche | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 29,527.6 | 0.0 | 40,057.0 |
| Employees | 69,000 | 5,000 | 98,213 |
| Market Cap ($ mil.) | 79,660.8 | -- | 96,562.0 |
Competitive Landscape
